Medical Health & Life Science Research News

Bacterial vaginosis pipeline market for therapeutics available in new report

The Bacterial Vaginosis Pipeline Review, H2 2017 guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- Agency -.

The Bacterial Vaginosis pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

Key players of Bacterial Vaginosis pipeline Evofem Inc, Osel Inc, Starpharma Holdings Ltd, Symbiomix Therapeutics LLC. Bacterial vaginosis (BV), also known as vaginal bacteriosis is a type of vaginal inflammation caused by overgrowth of bacteria present in vagina.

Symptoms include vaginal itching; burning during urination and vaginal discharge may become watery and thin.

- Agency -.

Treatment includes antibiotics.

Report: www.reportsnreports.com/contacts/.aspx?name=1132626

Bacterial Vaginosis - Drug Profiles

Amphora, astodrimer, LACTIN-V, secnidazole, subtilosin, TOL-463

Bacterial vaginosis (BV), also known as vaginal bacteriosis is a type of vaginal inflammation caused by overgrowth of bacteria present in vagina. Symptoms include vaginal itching; burning during urination and vaginal discharge may become watery and thin.

Treatment includes antibiotics.

Access Complete Report On Bacterial Vaginosis Pipeline Review, H2 2017: www.reportsnreports.com/.aspx?name=1132626

Scope

The report provides a snapshot of the global therapeutic landscape of Bacterial Vaginosis. The report reviews pipeline therapeutics for Bacterial Vaginosis by companies and universities/research institutes based on information derived from company and industry-specific sources.

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages. The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities.

The report reviews key players involved Bacterial Vaginosis therapeutics and enlists all their major and minor projects. The report assesses Bacterial Vaginosis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

The report summarizes all the dormant and discontinued pipeline projects. The report reviews latest news related to pipeline therapeutics for Bacterial Vaginosis

List of Tables
Number of Products under Development for Bacterial Vaginosis, H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products under Development by Universities/Institutes, H2 2017
Products under Development by Companies, H2 2017
Products under Development by Universities/Institutes, H2 2017
Number of Products by Stage and Target, H2 2017
Number of Products by Stage and Mechanism of Action, H2 2017
Number of Products by Stage and Route of Administration, H2 2017
Number of Products by Stage and Molecule Type, H2 2017
Bacterial Vaginosis - Pipeline by Evofem Inc, H2 2017
Bacterial Vaginosis - Pipeline by Osel Inc, H2 2017
Bacterial Vaginosis - Pipeline by Starpharma Holdings Ltd, H2 2017
Bacterial Vaginosis - Pipeline by Symbiomix Therapeutics LLC, H2 2017
Bacterial Vaginosis - Dormant Projects, H2 2017
Bacterial Vaginosis - Discontinued Products, H2 2017

 

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany profile: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets.